Liver Biology and Pathobiology

You have full text access to this OnlineOpen article

Endogenous interferon γ protects against cholestatic liver injury in mice

  1. Miguel E. Sewnath1,
  2. Tom Van Der Poll2,3,
  3. Cornelis J. F. Van Noorden4,
  4. Fiebo J. W. Ten Kate5,
  5. Dirk J. Gouma M.D.4,*

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360624

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1466–1477, December 2002

Additional Information

How to Cite

Sewnath, M. E., Van Der Poll, T., Van Noorden, C. J. F., Ten Kate, F. J. W. and Gouma, D. J. (2002), Endogenous interferon γ protects against cholestatic liver injury in mice. Hepatology, 36: 1466–1477. doi: 10.1002/hep.1840360624

Author Information

  1. 1

    Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  2. 2

    Department Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  3. 3

    Department Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  4. 4

    Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  5. 5

    Department Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

*G4-Suite 126, Department of Surgery, Academic Medical Center, Amsterdam, PO Box 22700, 1100 DE, Amsterdam, The Netherlands. fax: (31) 20–6914858

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007
  3. Manuscript Accepted: 26 SEP 2002
  4. Manuscript Received: 11 JUN 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (1282K)

Reference

  • 1
    Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984; 71: 234–238.
    Direct Link:
  • 2
    Reynolds JV, Murchan P, Redmond HP, Watson RW, Leonard N, Hill A, Clarke P, et al. Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg 1995; 82: 534–538.
    Direct Link:
  • 3
    Clements WD, McCaigue M, Erwin P, Halliday I, Rowlands BJ. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38: 925–931.
  • 4
    Greve JW, Maessen JG, Tiebosch T, Buurman WA, Gouma DJ. Prevention of postoperative complications in jaundiced rats. Internal biliary drainage versus oral lactulose. Ann Surg 1990; 212: 221–227.
  • 5
    Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotoxemia, disturbance of coagulation, and obstructive jaundice. Am J Surg 1982; 144: 325–329.
  • 6
    Karsten TM, Allema JH, Reinders M, van Gulik TM, de Wit LT, Verbeek PC, Huibregtse K, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 1996; 162: 881–888.
  • 7
    Coulter KR, Doseff A, Sweeney P, Wang Y, Marsh CB, Wewers MD, Knoell DL, et al. Opposing effect by cytokines on fas-mediated apoptosis in A549 lung epithelial cells. Am J Respir Cell Mol Biol 2002; 26: 58–66.
  • 8
    Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15: 749–795.
  • 9
    Bach EA, Aguet M, Schreiber RD. The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997; 15: 563–591.
  • 10
    Pestka S, Kotenko SV, Muthukumaran G, Izotova LS, Cook JR, Garotta G. The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev 1997; 8: 189–206.
  • 11
    Langer J, Garotta G, Pestka S. Interferon receptors. Biotherapy 1996; 8: 163–174.
  • 12
    Rashidbaigi A, Langer JA, Jung V, Jones C, Morse HG, Tischfield JA, Trill JJ, et al. The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sci U S A 1986; 83: 384–388.
  • 13
    Jung V, Rashidbaigi A, Jones C, Tischfield JA, Shows TB, Pestka S. Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A 1987; 84: 4151–4155.
  • 14
    Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vileck J, et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259: 1742–1745.
  • 15
    Sewnath ME, van der Poll T, ten Kate JWF, Van Noorden CJ, Gouma DJ. Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin. Hepatology 2002; 35: 149–158.
    Direct Link:
  • 16
    Sewnath ME, Levels JHM, Ou de Elferink RP, Van Noorden CJF, ten Kate JWF, van Deventer SJH, Gouma DJ. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein. Hepatology 2000; 32: 1289–1299.
    Direct Link:
  • 17
    Kerr JF, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods J Cell Biol 1995; 46: 1–27.
  • 18
    Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest.) J Immunol 1994; 153: 1778–1788.
  • 19
    Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M, Tanaka N. Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol 2000; 15: 443–451.
    Direct Link:
  • 20
    Lechner AJ, Velasquez A, Knudsen KR, Johanns CA, Tracy TF Jr, Matuschak GM. Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998; 157: 1550–1558.
  • 21
    Sekiya H, Komatsu T, Isono E, Furukawa M, Matsushima S, Yamaguchi N, Yamauchi K, et al. Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with advanced stage of primary biliary cirrhosis. Am J Gastroenterol 1999; 94: 3589–3594.
    Direct Link:
  • 22
    Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264–274.
  • 23
    Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 1998; 187: 2103–2108.
  • 24
    Camoglio L, te Velde AA, de Boer A, ten Kate FJ, Kopf M, van Deventer SJH. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol 2000; 30: 1486–1495.
    Direct Link:
  • 25
    Cockfield SM, Ramassar V, Noujaim J, van der Meide PH, Halloran PF. Regulation of IFN-γ expression in vivo. IFN-γ up-regulates expression of its mRNA in normal and lipopolysaccharide-stimulated mice. J Immunol 1993; 150: 717–725.
  • 26
    Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression. Evidence that IFN-γ induces its own expression in remote sites. J Immunol 1992; 148: 3837–3846.
  • 27
    Di Marzio P, Puddu P, Conti L, Belardelli F, Gessani S. Interferon γ upregulates its own gene expression in mouse peritoneal macrophages. J Exp Med 1994; 179: 1731–1736.
  • 28
    Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15: 1132–1136.
    Direct Link:
  • 29
    Ezure T, Sakamoto T, Tsuji H, Lunz JG, Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 2000; 156: 1627–1639.
  • 30
    Kimmings AN, van Deventer SJ, Obertop H, Gouma DJ. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats. J Am Coll Surg 1999; 189: 374–379.
  • 31
    Diamond T, Rowlands BJ. Endotoxaemia in obstructive jaundice. HPB Surg 1991; 4: 81–94.
  • 32
    Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg 1995; 181: 567–581.
  • 33
    O'Neil S, Hunt J, Filkins J, Gamelli R. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-α and systemic and tissue tumor necrosis factor-α levels after endotoxin. Surgery 1997; 122: 281–286.
  • 34
    Swain MG, Appleyard CB, Wallace JL, Maric M. TNF-α facilitates inflammation-induced glucocorticoid secretion in rats with biliary obstruction. J Hepatol 1997; 26: 361–368.
  • 35
    Bemelmans MH, Gouma DJ, Buurman WA. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 1994; 6: 608–615.
  • 36
    Beierle EA, Vauthey JN, Moldawer LL, Copeland EM 3rd. Hepatic tumor necrosis factor-α production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg 1996; 171: 202–206.
  • 37
    Leon LR, White AA, Kluger MJ. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol 1998; 275: R269–R277.
  • 38
    Chung IY, Benveniste EN. Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1 β. J Immunol 1990; 144: 2999–3007.
  • 39
    Gaudio E, Onori P, Pannarale L, Alvaro D. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology 1996; 111: 1118–1124.
  • 40
    Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, et al. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. Hepatology 1996; 23: 1159–1166.
  • 41
    Akyol G, Dursun A, Poyraz A, Uluoglu O, Ataoglu O, Edaly N, Memis L. P53 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases. Pathol Int 1999; 49: 214–221.
    Direct Link:
  • 42
    Harrison RF, Reynolds GM, Rowlands DC. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions. J Pathol 1993; 171: 115–122.
    Direct Link:
  • 43
    Nakajima T, Kagawa K, Ueda K, Ohkawara T, Kimura H, Kakusui M, Deguchi T, et al. Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues. J Gastroenterol 1994; 29: 450–454.
  • 44
    Satoh M, Yamazaki M. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor β and interleukin 6. J Cell Physiol 1992; 150: 134–139.
    Direct Link:
  • 45
    Fausto N. Growth factors in liver development, regeneration and carcinogenesis. Proc Growth Factor Res 1991; 3: 219–234.
  • 46
    Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569–3577.
  • 47
    Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995; 378: 88–91.
  • 48
    Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999; 117: 669–677.
  • 49
    Muschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Haussinger D. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 1999; 116: 666–677.
Get PDF (1282K)